Key result
Silent myocardial ischaemia commonly occurs in patients with coronary artery disease and has important prognostic implications, though its optimal management remains debated.
Why the study?
How should silent myocardial ischaemia be managed in patients with coronary artery disease?
How should silent myocardial ischaemia be managed in patients with coronary artery disease?
This review discusses the clinical relevance, prognostic implications, and potential pharmacological management of silent myocardial ischaemia in patients with coronary artery disease.
No takes yet. Share an insight, caveat, or question.
Does not support practice changes yet; leaves open optimal pharmacological strategies pending RCTs.
Kaski et al. (2005) conducted a review in Silent myocardial ischaemia in coronary artery disease. Medical or surgical treatment was evaluated. Silent myocardial ischaemia commonly occurs in patients with coronary artery disease and has important prognostic implications, though its optimal management remains debated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: